© 1993 Oxford University Press
OTHER |
Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene
1Molecular Genetics Department, Cancer Research Institute, I.R.O. Hospital Duran y Reynals 08907 Barcelona, Catalonia 2Servei de Dermatologia, Hospital de la Creu Roja 08025 Barcelona, Catalonia 3Servei de Genètica, Hospital Clínic i Provincial 08036 Barcelona, Catalonia, Spain
*To whom correspondence should be addressed at: Molecular Genetics Department, Cancer Research Institute, IRO, Hospital Duran y Reynals, 08907 Barcelona, Catalonia, Spain
Received February 10, 1993; Revised April 9, 1993; Accepted April 9, 1993
Neurofibromatosis type 1 (NF1) (von Recklinghausen) is a common autosomal dominant disorder, characterised by the presence of peripheral neurofibromas, café-au-lait spots and Lisch nodules of the iris. Due to the high mutation rate at the NF1 locus, most patients are expected to have different mutations, limiting molecular analysis and genetic counseling to the identification of the mutation in each patient or family, or to the use of DNA polymorphisms. We have analysed an Alu-repeat polymorphic sequence (AAAT), located in intron 27 of the NF1 gene, in 70 NF1 and 40 CEPH families and we have detected several genetic and molecular abnormalities. In two families the NF1 individuals were hemizygous at the AAAT-repeat and/or at the CA-repeat of intron 27 of NF1, due to interstitial deletions, which include intron 27 to exon 37 of the NF1 gene. A 71-bp deletion at the Alu sequence was detected in non-NF1 chromosomes of members of three NF1 families. New alleles at the AAAT-repeat were found in one NF1 family and in three CEPH families giving a mutation rate for this AAAT-repeat of 0.36% per allele, which is one of the highest detected for a microsatellite locus.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Brems, C. Park, O. Maertens, A. Pemov, L. Messiaen, M. Upadhyaya, K. Claes, E. Beert, K. Peeters, V. Mautner, et al. Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association Cancer Res., September 15, 2009; 69(18): 7393 - 7401. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Maertens, H. Prenen, M. Debiec-Rychter, A. Wozniak, R. Sciot, P. Pauwels, I. De Wever, J. R. Vermeesch, T. de Raedt, A. De Paepe, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients Hum. Mol. Genet., March 15, 2006; 15(6): 1015 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Ars, H Kruyer, M Morell, E Pros, E Serra, A Ravella, X Estivill, and C Lazaro Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients J. Med. Genet., June 1, 2003; 40(6): e82 - 82. [Full Text] [PDF] |
||||
![]() |
E. Ars, E. Serra, J. Garcia, H. Kruyer, A. Gaona, C. Lazaro, and X. Estivill Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 Hum. Mol. Genet., January 22, 2000; 9(2): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lazaro, A. Ravella, A. Gaona, V. Volpini, and X. Estivill Neurofibromatosis Type 1 Due to Germ-Line Mosaicism in a Clinically Normal Father N. Engl. J. Med., November 24, 1994; 331(21): 1403 - 1407. [Abstract] [Full Text] |
||||



